CONNEQT Health Ltd. Stock Analysis CQT.AX
Conneqt Health Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. The firm's suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular diseases, and other vascular health disorders, all based on its SphygmoCor vascular biomarker technology. Its SphygmoCor vascular biosensing technology measures arterial health by collecting clinically meaningful digital vascular biomarkers using novel sensors. These biomarkers represent key indicators of cardiovascular health including central blood pressures, vascular stiffness, vascular age, and heart stress. The company offers CONNEQT, which is a clinical-grade arterial assessment that provides professional-level arterial health insights.
Read More CONNEQT Health Ltd (CQT.AX) Chart
Key Statistics of CONNEQT Health Ltd (CQT.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.04Volume
24.53KP/E Ratio (TTM)
-52 Week Range
Market Cap
23.17MAvg. Volume
-Dividend Yield
-Financial Metrics & Statements of CONNEQT Health Ltd (CQT.AX)
FAQ's for CONNEQT Health Ltd (CQT.AX)
- According to Musaffa’s Shariah screening methodology, CONNEQT Health Ltd (CQT.AX) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.